- Home
- KRRO vs QTRX Comparison
KRRO vs QTRX Comparison
Compare KRRO & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- QTRX
- Stock Information
- Founded
- KRRO 2014
- QTRX 2007
- Country
- KRRO United States
- QTRX United States
- Employees
- KRRO N/A
- QTRX N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- KRRO Health Care
- QTRX Industrials
- Exchange
- KRRO Nasdaq
- QTRX Nasdaq
- Market Cap
- KRRO 209.6M
- QTRX 233.5M
- IPO Year
- KRRO 2019
- QTRX 2017
- Fundamental
- Price
- KRRO $11.82
- QTRX $5.18
- Analyst Decision
- KRRO Strong Buy
- QTRX Buy
- Analyst Count
- KRRO 7
- QTRX 5
- Target Price
- KRRO $85.67
- QTRX $15.60
- AVG Volume (30 Days)
- KRRO 89.6K
- QTRX 676.0K
- Earning Date
- KRRO 05-07-2025
- QTRX 05-12-2025
- Dividend Yield
- KRRO N/A
- QTRX N/A
- EPS Growth
- KRRO N/A
- QTRX N/A
- EPS
- KRRO N/A
- QTRX N/A
- Revenue
- KRRO $4,821,000.00
- QTRX $135,688,000.00
- Revenue This Year
- KRRO $20.96
- QTRX N/A
- Revenue Next Year
- KRRO N/A
- QTRX $14.75
- P/E Ratio
- KRRO N/A
- QTRX N/A
- Revenue Growth
- KRRO N/A
- QTRX 7.71
- 52 Week Low
- KRRO $11.00
- QTRX $4.05
- 52 Week High
- KRRO $98.00
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- KRRO 34.02
- QTRX 48.92
- Support Level
- KRRO $14.54
- QTRX $4.60
- Resistance Level
- KRRO $16.68
- QTRX $5.40
- Average True Range (ATR)
- KRRO 1.49
- QTRX 0.46
- MACD
- KRRO -0.33
- QTRX 0.08
- Stochastic Oscillator
- KRRO 6.24
- QTRX 64.61
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.